Retrospective analysis of Benvenue Medical’s Luna® 3D Multi-Expandable Interbody Fusion system indicate that minimally invasive placement of the device in transforaminal lumbar interbody fusion was safe and effective, leading to improved pain and disability scores and consistent restoration of disc height.
The retrospective analysis evaluated 31 Luna patients at a single center who had at least six months of post-op follow-up. All but one patient experienced improvement in pain scores from baseline, and disability scores improved for all patients. Any spondylolisthesis was reduced significantly, and no graft subsidence or hardware failure occurred.
The PEEK-based Luna 3D device is designed to expand in multiple dimensions within the disc space, first in footprint, second in height and third in lordosis. The system launched in the U.S. in 4Q15, and by 2Q16, had been employed in over 500 procedures.
Retrospective analysis of Benvenue Medical's Luna® 3D Multi-Expandable Interbody Fusion system indicate that minimally invasive placement of the device in transforaminal lumbar interbody fusion was safe and effective, leading to improved pain and disability scores and consistent restoration of disc height.
The retrospective analysis evaluated...
Retrospective analysis of Benvenue Medical’s Luna® 3D Multi-Expandable Interbody Fusion system indicate that minimally invasive placement of the device in transforaminal lumbar interbody fusion was safe and effective, leading to improved pain and disability scores and consistent restoration of disc height.
The retrospective analysis evaluated 31 Luna patients at a single center who had at least six months of post-op follow-up. All but one patient experienced improvement in pain scores from baseline, and disability scores improved for all patients. Any spondylolisthesis was reduced significantly, and no graft subsidence or hardware failure occurred.
The PEEK-based Luna 3D device is designed to expand in multiple dimensions within the disc space, first in footprint, second in height and third in lordosis. The system launched in the U.S. in 4Q15, and by 2Q16, had been employed in over 500 procedures.
Copy to clipboard 
